BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cyclacel Limited 

James Lindsay Place
Dundee Technopole
Dundee    DD1 5JJ  United Kingdom
Phone: 44-1382-206-062 Fax: 44-1382-206-067


SEARCH JOBS










 Company News
Cyclacel Limited (CYCC) Answers Celgene (CELG)'s Declaratory Judgment Complaint and Counterclaims for Infringement of Four Cyclacel Patents 6/18/2010 9:13:42 AM    More...
Cyclacel Limited (CYCC) Receives Complaint Filed by Celgene Corporation (CELG) Seeking to Avoid Certain Cyclacel Patents 5/3/2010 10:22:14 AM    More...
Cyclacel Limited (CYCC) Announces Publication of Peer-Reviewed Journal Article Describing the Mechanism of Action of Seliciclib 12/30/2009 10:08:36 AM    More...
Cyclacel Limited (CYCC) Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 American Society of Hematology Annual Meeting 12/7/2009 8:48:59 AM    More...
Cyclacel Limited (CYCC) to Present At Annual Needham Biotechnology and Medical Technology Conference 6/9/2009 9:24:37 AM    More...
Cyclacel Limited (CYCC) Advances Oral Sapacitabine Pivotal Trial Plan in Hematological Malignancies 2/6/2009 6:36:29 AM    More...
Cyclacel Limited (CYCC) Announces Completion of Enrollment in Phase 2 Trial of Sapacitabine in Elderly AML 10/9/2008 11:12:41 AM    More...
Cyclacel Limited (CYCC) to Present at Annual Needham Biotechnology & Medical Technology Conference 6/5/2008 12:58:37 PM    More...
Cyclacel Limited (CYCC) Reports Second Quarter 2006 Financial Results 8/15/2006 10:57:50 AM    More...
Xcyte Therapies, Inc. Stockholders Approve Transaction With Cyclacel Group plc 3/17/2006 12:27:22 PM    More...
1234